RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

M2a Magnum (hip implant)

Product
Developers: Zimmer Biomet
Branches: Pharmaceuticals, medicine, healthcare

2020: Zimmer Biomet will pay a fine for defective hip implants

At the end of November 2020, a US federal court ordered Zimmer Biomet to pay $21 million to the Bayesov couple and another $3.55 million to the Nicholsons for the release of defective M2a Magnum hip implants. Zimmer Biomet officials were "disappointed by the inconsistent jury verdict" in the first case, the jury verdict in the second case, they said, "contradicted the evidence presented in court."

Missouri District Judge Stephen R. Clark called on Zimmer Biomet to pay $20 million to Mary Bayes and $1 million to her husband Philip Bayes, and the day before, a federal jury in Iowa awarded $3.55 million to Laurie Nicholson and her husband Willis as a result of an implantation by them for injuries, Mum The company plans to appeal both cases.

Zimmer Biomet to pay penalty for defective M2a Magnum hip implants
File:Aquote1.png
The M2a femoral implant helped thousands of patients successfully regain mobility.<…> Our commitment to safety and quality defines every decision we make, and we consider it our mission to help patients with pain syndrome and improve the quality of life of people around the world.
File:Aquote2.png

Metal and metal implants became one of the most serious failures of the medical equipment industry at the beginning of the 21st century. It was believed that such femoral implants should be stronger and more durable, but in fact the frequency of adverse events increased dramatically due to the exposure to toxic metal particles released by implants during friction.

In 2016, regulators ordered companies to test metal-metal hip implants before entering the market, and currently there are no approved devices of this type in the US market for full hip prosthetics. However, lawsuits continue to be filed, including in connection with M2a Zimmer Biomet.[1]

Notes